Themis Medicare (Themis) has entered into a License and Supply Agreement with Novartis India (Novartis) on March 26, 2013. As per agreement, Themis has agreed to manufacture and supply Diclofenac topical gel formulated using unique TPM transdermal drugs delivery system in finished dosage pharmaceutical form on certain commercial terms and conditions. Novartis has agreed to purchase the same.
Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.
